Table 14.4

Recipient De Novo Post Transplant Lymphoproliferative Disorders (PTLD), 1997 to 2006

by Transplant Type

Organ Type Year of Transplant
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total Total Recipients 20,322 21,542 22,045 23,266 24,244 24,919 25,484 27,048 28,109 28,931
# With PTLD (1) 306 286 255 232 248 228 188 139 103 38
% With PTLD (1) 1.5% 1.3% 1.2% 1.0% 1.0% 0.9% 0.7% 0.5% 0.4% 0.1%
Kidney Total Recipients 11,701 12,452 12,760 13,612 14,266 14,779 15,137 16,004 16,481 17,093
# With PTLD (1) 107 116 106 91 102 101 81 63 38 9
% With PTLD (1) 0.9% 0.9% 0.8% 0.7% 0.7% 0.7% 0.5% 0.4% 0.2% 0.1%
Pancreas Transplant Alone Total Recipients 79 88 139 134 167 180 158 182 198 169
# With PTLD (1) - 2 2 2 5 5 3 2 3 3
% With PTLD (1) - 2.3% 1.4% 1.5% 3.0% 2.8% 1.9% 1.1% 1.5% 1.8%
Pancreas After Kidney Total Recipients 130 156 220 304 305 375 344 420 343 293
# With PTLD (1) - 4 3 2 5 3 - 3 3 -
% With PTLD (1) - 2.6% 1.4% 0.7% 1.6% 0.8% - 0.7% 0.9% -
Kidney-Pancreas Total Recipients 853 972 941 915 891 905 871 881 903 924
# With PTLD (1) 18 7 13 6 9 7 5 3 5 2
% With PTLD (1) 2.1% 0.7% 1.4% 0.7% 1.0% 0.8% 0.6% 0.3% 0.6% 0.2%
Liver Total Recipients 4,188 4,516 4,751 4,995 5,191 5,331 5,673 6,169 6,441 6,649
# With PTLD (1) 77 65 71 60 50 57 35 39 20 16
% With PTLD (1) 1.8% 1.4% 1.5% 1.2% 1.0% 1.1% 0.6% 0.6% 0.3% 0.2%
Intestine Total Recipients 68 70 73 82 112 107 116 152 176 174
# With PTLD (1) 8 3 1 5 9 5 9 4 4 4
% With PTLD (1) 11.8% 4.3% 1.4% 6.1% 8.0% 4.7% 7.8% 2.6% 2.3% 2.3%
Heart Total Recipients 2,293 2,348 2,188 2,199 2,202 2,155 2,057 2,015 2,125 2,192
# With PTLD (1) 59 55 30 36 32 25 31 13 14 1
% With PTLD (1) 2.6% 2.3% 1.4% 1.6% 1.5% 1.2% 1.5% 0.6% 0.7% 0.0%
Lung Total Recipients 948 893 922 977 1,083 1,054 1,099 1,185 1,407 1,406
# With PTLD (1) 31 32 27 26 35 23 23 11 16 3
% With PTLD (1) 3.3% 3.6% 2.9% 2.7% 3.2% 2.2% 2.1% 0.9% 1.1% 0.2%
Heart-Lung Total Recipients 62 47 51 48 27 33 29 40 35 31
# With PTLD (1) 6 2 2 4 1 2 1 1 - -
% With PTLD (1) 9.7% 4.3% 3.9% 8.3% 3.7% 6.1% 3.4% 2.5% - -


Source: OPTN/SRTR Data as of May 1, 2007.

(-) = None in category.

(1) PTLD: Post Transplant Lymphoproliferative Disorders.

Year indicates the year of transplant, not the year of cancer diagnosis. Includes both deceased and living donor transplants.

Percent decreases in later years because of limited follow-up. Recipient malignancy statistics are based on voluntary reporting to the OPTN.